Detalhe da pesquisa
1.
Identification of Optimal Urinary Biomarkers of Synthetic Cannabinoids BZO-HEXOXIZID, BZO-POXIZID, 5F-BZO-POXIZID, and BZO-CHMOXIZID for Illicit Abuse Monitoring.
Clin Chem
; 68(11): 1436-1448, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36175111
2.
Urinary Metabolite Biomarkers for the Detection of Synthetic Cannabinoid ADB-BUTINACA Abuse.
Clin Chem
; 67(11): 1534-1544, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34387654
3.
Diagnosing intake and rationalizing toxicities associated with 5F-MDMB-PINACA and 4F-MDMB-BINACA abuse.
Arch Toxicol
; 95(2): 489-508, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33236189
4.
Characterization of iso-LSD metabolism using human liver microsomes in comparison to LSD and its applicability as urinary biomarker for LSD consumption.
J Anal Toxicol
; 48(5): 281-288, 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38613436
5.
Transesterification of Indazole-3-carboxamide Synthetic Cannabinoids: Identification of Metabolite Biomarkers for Diagnosing Co-abuse of 5F-MDMB-PINACA and Alcohol.
J Anal Toxicol
; 46(9): 1016-1024, 2023 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34918103
6.
Qualitative Confirmation of 94 New Psychoactive Substances and Metabolites in Urine Using Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry.
J Anal Toxicol
; 47(4): 366-378, 2023 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36715077
7.
Advances in urinary biomarker research of synthetic cannabinoids.
Adv Clin Chem
; 115: 1-32, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37673518